← All trials
NCT02354131
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2015
- Primary completion
- Nov 1, 2018
- Completion date
- Dec 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 108
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Nordic Society for Gynaecologic OncologyLead sponsor
- Myrexis Inc.Collaborator
- Nordic Society for Gynaecologic OncologyStudy chair
- University of UtahCollaborator
- Harvard UniversityCollaborator
- European Network for Gynaecological Oncological TrialCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.